<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03906994</url>
  </required_header>
  <id_info>
    <org_study_id>19-000212</org_study_id>
    <nct_id>NCT03906994</nct_id>
  </id_info>
  <brief_title>Treating Amblyopia in Adults With Interactive Video Games</brief_title>
  <official_title>Treating Amblyopia in Adults With Interactive Video Games</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Researchers are trying to determine whether interactive video game play, while wearing a
      patch over better-seeing eye, will improve subject reduced vision (amblyopia).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this research is to determine whether amblyopia (reduced vision in one eye) in
      adults can be improved using interactive video game play.

      Study participation involves playing the video game Mario KartTM (provided by the study),
      while wearing a patch over their better-seeing eye. Participants are asked to play the game
      for a total of 40 hours over a one-month period.

      The primary outcome measure will be LogMAR visual acuity measured 1 month after initiating
      game play.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 1, 2019</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in visual acuity</measure>
    <time_frame>Baseline, one month</time_frame>
    <description>measured using the LogMAR (Logarithm of the Minimum Angle of Resolution) chart comprised of rows of letters to estimate visual acuity</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">23</enrollment>
  <condition>Amblyopia</condition>
  <arm_group>
    <arm_group_label>Subjects with Amblyopia</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Adult amblyopia subjects will play the video game Mario Kart Wii</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Video game Mario Kart Wii</intervention_name>
    <description>Subjects will place a patch over the better-seeing eye and play the video game Mario Kart Wii for a total of 40 hours over a 1 month perior</description>
    <arm_group_label>Subjects with Amblyopia</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Aged &gt;17 years old

          -  Refraction within past year and wearing updated glasses or contact lenses

          -  Diagnosis of strabismic, anisometropic or combined amblyopia (&gt; 2 lines inter-ocular
             difference)

          -  Stable visual acuity as defined as &lt;1 LogMAR change over 2 visits 8 weeks apart, or
             wearing glasses for at least 16 weeks

        Exclusion Criteria:

          -  Monovision and unwilling to wear corrective glasses

          -  Allergy to adhesive bandages

          -  Women who are currently pregnant
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jonathan M Holmes</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Suzanne M Wernimont, CCRP</last_name>
    <phone>507-266-4326</phone>
    <email>wernimont.suzanne@mayo.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>David A Leske, MS</last_name>
    <phone>507-284-3093</phone>
    <email>leske.david@mayo.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Mayo Clinic in Rochester</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.mayo.edu/research/clinical-trials</url>
    <description>Mayo Clinic Clinical Trials</description>
  </link>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>April 5, 2019</study_first_submitted>
  <study_first_submitted_qc>April 5, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 8, 2019</study_first_posted>
  <last_update_submitted>November 8, 2019</last_update_submitted>
  <last_update_submitted_qc>November 8, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 13, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Jonathan M. Holmes</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Amblyopia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

